catechin has been researched along with Herpes Simplex Virus Infection in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, SD; Cantatore, A; Randall, SD; Traum, D | 1 |
Hillier, S; Isaacs, CE; Merz, G; Rohan, L; Wen, GY; Xu, W | 1 |
Adams, SD; Chen, P; Chu, TC; de Oliveira, A; Dickinson, D; Hammond, JR; Hsu, SD; Lee, LH; Murray, SR | 1 |
Corbo, C; Di Maggio, V; Hillier, S; Isaacs, CE; Jenkins, EC; Jia, JH; Rohan, L; Wen, GY; Xu, W | 1 |
McKeough, M; McKinley, G; Robinson, D; Safrin, S; Spruance, SL | 1 |
Bassetti, D; Canessa, A; Cruciani, M; Ferrea, G; Romussi, G; Sampietro, F | 1 |
Armendariz, AM; Cano-Dominguez, C; Fernandez, H; Garcia-Cosio, C; Kershenovich, J; Orozco-Topete, R; Ortiz-Pedroza, G; Romo-Garcia, J; Rozhon, EJ; Sierra-Madero, J; Soria-Cordoba, A; Teran-Toledo, X; Vazquez-Valls, E | 1 |
1 trial(s) available for catechin and Herpes Simplex Virus Infection
Article | Year |
---|---|
Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Diseases; Biopolymers; Catechin; Double-Blind Method; Female; Follow-Up Studies; Herpes Genitalis; Herpes Simplex; Humans; Male; Middle Aged; Molecular Structure; Pain; Time Factors; Virus Shedding | 1997 |
7 other study(ies) available for catechin and Herpes Simplex Virus Infection
Article | Year |
---|---|
Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.
Topics: Animals; Antiviral Agents; Biflavonoids; Camellia sinensis; Catechin; Cell Line; Cell Survival; Chlorocebus aethiops; Herpes Simplex; Herpesvirus 1, Human; Humans; Plant Extracts; Vero Cells; Viral Plaque Assay; Virus Replication | 2013 |
Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.
Topics: Animals; Antiviral Agents; Benzopyrans; Catechin; Chlorocebus aethiops; Depsides; Dimerization; Gallic Acid; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Hydrogen-Ion Concentration; Microscopy, Electron; Phenols; Vero Cells; Virus Inactivation | 2011 |
Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.
Topics: Animals; Antigens, Viral; Antiviral Agents; Catechin; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Green Fluorescent Proteins; Herpes Simplex; Herpesvirus 1, Human; Microscopy, Fluorescence; Tea; Vero Cells; Viral Envelope Proteins; Viral Proteins | 2013 |
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
Topics: Animals; Catechin; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microscopy, Electron; Vero Cells; Virion; Virus Inactivation | 2008 |
Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Topical; Adult; Aged; Biopolymers; Catechin; Drug Resistance, Microbial; Herpes Simplex; Humans; Male; Middle Aged | 1994 |
In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2.
Topics: Animals; Antiviral Agents; Catechin; Chlorocebus aethiops; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Microbial Sensitivity Tests; Plant Extracts; Vero Cells; Viral Plaque Assay; Virus Replication | 1993 |
Herpes study and resources.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Biopolymers; Catechin; Clinical Trials as Topic; Complementary Therapies; Computer Communication Networks; Drug Resistance, Microbial; Famciclovir; Foscarnet; Gels; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Middle Aged; Patient Selection; Trifluridine | 1997 |